43 results
8-K
EX-2.2
DBTX
Decibel Therapeutics, Inc.
25 Sep 23
Completion of Acquisition or Disposition of Assets
8:56am
exceeding $1 billion or with an average rating above investment grade by S&P (LT Local Issuer Credit Rating), Moody’s (Long Term Rating) and Fitch Ratings
SC 14D9
DBTX
Decibel Therapeutics, Inc.
25 Aug 23
Tender offer solicitation
9:17am
business plan; and
the Transaction Committee’s familiarity with the business, operations, prospects, strategic and short and long term operating plans …
Decibel does not yet have any marketed products and does not publicly disclose long-term projections or internal forecasts as to future performance
SC TO-T
EX-99
DBTX
Decibel Therapeutics, Inc.
25 Aug 23
Third party tender offer statement
7:46am
, expatriates and former long-term residents of the United States, persons subject to the alternative minimum tax, holders holding Shares that are part … in a single transaction) exchanged in the Offer or the Merger. Such gain or loss will generally be capital gain or loss and will be long-term capital gain
SC TO-C
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
9 Aug 23
Information about tender offer
4:15pm
confidence that with Regeneron’s expertise and resources the Decibel pipeline can be optimally developed, and our team is committed to enabling that long … -term success.”
Decibel and Regeneron established their initial collaboration in 2017, with an extension announced in 2021, and are developing three
8-K
EX-99.2
so16d1
9 Aug 23
Tender and Support Agreement
8:02am
PRE 14A
kwn6dei8 ubwiq
14 Apr 23
Preliminary proxy
8:00am
DEF 14A
wmr3l6 7l
29 Apr 22
Definitive proxy
4:03pm
S-3
EX-1.2
tx0slr
18 Mar 22
Shelf registration
7:57am
10-Q
3jhad1
13 May 21
Quarterly report
4:06pm
10-K
cvy6ms
29 Mar 21
Annual report
5:08pm
424B4
7j1f m5j6
12 Feb 21
Prospectus supplement with pricing info
4:30pm